MetaCap

Dermata Therapeutics (DRMA) vs Onconetix (ONCO)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Dermata Therapeutics is the larger company by market cap ($2.5 million vs $2.4 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

DRMA-54.51%ONCO+383.92%
+1120%+505%-110%
Oct 7, 20261 yearNov 20, 2026
DRMA-50.05%ONCO+366.13%
+1075%+485%-104%
Oct 5, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

DRMA versus ONCO key metrics
MetricDRMAONCO
Share price$0.5095$2.89
Market cap$2.51M$2.37M
1-day change-4.23%-8.54%
P/E ratio (TTM)—0.00
EPS (TTM)$-3.28$4,509.80
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)—$815.37K
Revenue growth (YoY)—-67.70%
Net income (latest FY)$-7.56M$-14.03M
Gross margin—77.62%
Operating margin—-2190.03%
Net margin—-1720.98%
52-week high$4.66$1,610.00
52-week low$0.50$2.76
Distance from 52-week high-89.07%-99.82%
Analyst consensusnone—
Avg. price target upside+685.08%—
Average volume2.78M412.90K
Shares outstanding4.93M820.61K
Employees92
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Dermata Therapeutics

DRMA stock →

Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States.

Health Care · Biotechnology: Pharmaceutical Preparations · 9 employees

About Onconetix

ONCO stock →

Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer.

Health Care · Biotechnology: Pharmaceutical Preparations · 2 employees

DRMA vs ONCO FAQ

Which is bigger, Dermata Therapeutics or Onconetix?

Dermata Therapeutics (DRMA) is larger, with a market capitalization of $2.51M compared with $2.37M for Onconetix (ONCO).

Are Dermata Therapeutics and Onconetix in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons